Corcept Therapeutics Incorporated
US ˙ NasdaqCM ˙ US2183521028

SecurityCORT / Corcept Therapeutics Incorporated
InstitutionAxa S.a.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Axa S.a. closes position in CORT / Corcept Therapeutics Incorporated

On August 14, 2025 - Axa S.a. filed a 13F-HR form disclosing ownership of 0 shares of Corcept Therapeutics Incorporated (US:CORT) valued at $0 USD as of June 30, 2025. The entity filed a previous 13F-HR on May 15, 2025 disclosing 4,990 shares of Corcept Therapeutics Incorporated. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-08-14 2025-06-30 13F CORCEPT THERAPEUTICS COM 218352102 0 -100.00 0
2025-05-15 2025-03-31 13F CORCEPT THERAPEUTICS COM 218352102 4,990 -24,850 -83.28 570 -62.14 0.0013
2025-02-14 2024-12-31 13F CORCEPT THERAPEUTICS COM 218352102 29,840 20,023 203.96 1,504 231.06 0.0046
2024-11-14 2024-09-30 13F CORCEPT THERAPEUTICS COM 218352102 9,817 -3,131 -24.18 454 8.10 0.0013
2025-02-25 2024-06-30 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 12,948 -9,674 -42.76 421 -26.19 0.0013
2024-08-14 2024-06-30 13F CORCEPT THERAPEUTICS COM 218352102 12,948 -9,674 421 0.0013
2024-05-15 2024-03-31 13F CORCEPT THERAPEUTICS COM 218352102 22,622 22,622 570 0.0017
2023-05-15 2023-03-31 13F CORCEPT THERAPEUTICS COM 218352102 0 -61,700 -100.00 0 -100.00
2023-02-14 2022-12-31 13F CORCEPT THERAPEUTICS COM 218352102 61,700 36,000 140.08 1,253 90.43 0.0045
2023-02-14 2022-09-30 13F/A-1 Corcept Therapeutics COM 218352102 25,700 -38,875 -60.20 659 -57.13 0.0026
2022-11-14 2022-09-30 13F Corcept Therapeutics COM 218352102 25,700 -38,875 659 0.0026
2023-02-14 2022-06-30 13F/A-1 Corcept Therapeutics COM 218352102 64,575 34,875 117.42 1,536 129.79 0.0057
2022-08-15 2022-06-30 13F Corcept Therapeutics COM 218352102 64,575 34,875 1,536 0.0057
2023-02-14 2022-03-31 13F/A-1 Corcept Therapeutics COM 218352102 29,700 29,700 669 0.0019
2022-05-13 2022-03-31 13F Corcept Therapeutics COM 218352102 29,700 29,700 669 0.0019
2021-11-13 2021-09-30 13F Corcept Therapeutics COM 218352102 0 -13,300 -100.00 0 -100.00
2021-08-13 2021-06-30 13F/A-1 Corcept Therapeutics COM 218352102 13,300 0 0.00 293 -7.28 0.0008
2021-08-13 2021-06-30 13F Corcept Therapeutics COM 218352102 13,300 0 293 0.0005
2021-05-14 2021-03-31 13F Corcept Therapeutics COM 218352102 13,300 0 0.00 316 -9.20 0.0010
2021-02-12 2020-12-31 13F Corcept Therapeutics COM 218352102 13,300 0 0.00 348 50.65 0.0011
2021-02-11 2020-09-30 13F/A-1 Corcept Therapeutics COM 218352102 13,300 0 0.00 231 3.13 0.0008
2020-11-13 2020-09-30 13F Corcept Therapeutics COM 218352102 13,300 0 231 461.1127
2021-02-12 2020-06-30 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 13,300 0 0.00 224 41.77 0.0009
2020-08-14 2020-06-30 13F CORCEPT THERAPEUTICS COM 218352102 13,300 0 224 883.3767
2021-02-12 2020-03-31 13F/A-2 CORCEPT THERAPEUTICS COM 218352102 13,300 0 0.00 158 -1.86 0.0008
2020-06-15 2020-03-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 13,300 0 158 0.0008
2020-05-15 2020-03-31 13F CORCEPT THERAPEUTICS COM 218352102 13,300 0 158 439.4007
2021-02-12 2019-12-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 13,300 0 0.00 161 -14.36 0.0007
2020-02-18 2019-12-31 13F CORCEPT THERAPEUTICS COM 218352102 13,300 0 161 655.5370
2021-02-12 2019-09-30 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 13,300 0 0.00 188 27.03 0.0007
2019-11-14 2019-09-30 13F CORCEPT THERAPEUTICS COM 218352102 13,300 0 188 749.1920
2021-02-12 2019-06-30 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 13,300 0 0.00 148 -5.13 0.0006
2019-08-13 2019-06-30 13F CORCEPT THERAPEUTICS COM 218352102 13,300 0 148 580.3938
2019-05-14 2019-03-31 13F CORCEPT THERAPEUTICS COM 218352102 13,300 0 0.00 156 -12.36 0.0006
2019-02-13 2018-12-31 13F CORCEPT THERAPEUTICS COM 218352102 13,300 0 0.00 178 -4.30 0.0008
2018-11-08 2018-09-30 13F CORCEPT THERAPEUTICS COM 218352102 13,300 -3,500 -20.83 186 -29.55 0.0007
2018-08-13 2018-06-30 13F CORCEPT THERAPEUTICS COM 218352102 16,800 -3,800 -18.45 264 -22.12 0.0010
2018-05-14 2018-03-31 13F CORCEPT THERAPEUTICS COM 218352102 20,600 20,600 339 0.0014
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.